Tandem Diabetes Care, Inc. TNDM Income Statement

Tandem diabetes care, inc. (TNDM)

Income statement / Yearly

Dec'19	Dec'18	Dec'17	Dec'16	Dec'15	Dec'14	Dec'13	Dec'12
Sales
362,305	183,866	107,601	84,248	72,850	49,722	29,007	2,475
Cost of sales
168,093	94,044	63,507	60,656	46,270	34,474	22,840	3,823
Gross profit
194,212	89,822	44,094	23,592	26,580	15,248	6,167	-1,348
Operating expenses:
Selling, general and administrative
165,735	105,226	86,377	82,834	78,621	75,121	44,522	22,691
Research and development
45,199	29,227	20,661	18,809	16,963	15,791	11,079	9,009
Total operating expenses
210,934	134,453	107,038	101,643	95,584	90,912	55,601	31,700
Operating loss
-16,722	-44,631	-62,944	-78,051	-69,004	-75,664	-49,434	-33,048
Other income (expense), net:
Interest and other income
3,271	1,462	239	296	337	112	7	2
Interest and other expense
78	7,584	11,341	5,707	3,741	3,901	4,710	2,525
Loss on extinguishment of debt
0	-5,313	0	-	-	-	-	-
Fair Value Adjustment of Warrants
11,075	66,494	-1,021	-	-	-	9,002	-2,556
Total other expense, net
-7,882	-77,929	-10,081	-5,411	-3,404	-3,789	-13,705	33
Loss before income taxes
-24,604	-122,560	-73,025	-83,462	-72,408	-79,453	-63,139	-33,015
Income tax expense
149	51	8	-15	10	71	-	-
Net Income (Loss) Attributable to Parent
-24,753	-122,611	-73,033	-83,447	-72,418	-79,524	-63,139	-33,015
Other comprehensive loss:
Unrealized gain on short-term investments
77	-13	1	-21	12	8	-	-
Foreign currency translation gain (loss)
58	0	0	-	-	-	-	-
Other comprehensive gain or loss:
Comprehensive loss
-24,618	-122,624	-73,032	-83,468	-72,406	-79,516	-63,139	-33,015
Net loss per share, basic and diluted (in dollars per share)
-0.42	-2.55	-12.87	-27.30	-25.04	-34.17	-21.46	-175.88
Weighted average shares used to compute basic and diluted net loss per share (in shares)
58,507	48,129	5,677	3,057	2,892	2,327	2,942	188